10 kcal% fat, 70 kcal% carbohydrate, 20 kcal% protein, Research Diets, Inc
Important safety questions include product purity, dose accuracy, drug interactions, liver and kidney considerations, blood sugar changes, cardiovascular risk, pregnancy or breastfeeding status, and long-term exposure
In fact, even when development as a prescription obesity drug slowed (after some longer trials showed only modest results), AOD-9604 found new life as a wellness peptide due to its excellent safety profile
nov., sp
No human clinical trials of 5-Amino-1MQ in obesity, sarcopenia, or any other indication have been published in peer-reviewed journals